Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 36.30% institutional investors, 3.86% insiders, and 59.84% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 36.30% | 3.86% | 59.84% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.33M | 7.35% | $23.25M |
| Blackrock funding, inc. /de | 12.64M | 7.12% | $99.22M |
| Vanguard group | 11.19M | 6.30% | $87.82M |
| Geode capital management | 4.28M | 2.41% | $33.57M |
| State street | 3.74M | 2.40% | $30.43M |
| Qube research | 3.27M | 2.10% | $26.66M |
| Driehaus capital management | 2.62M | 1.68% | $21.32M |
| Nuveen | 2.81M | 1.58% | $22.03M |
| Morgan stanley | 2.71M | 1.52% | $21.26M |
| Millennium management | 1.95M | 1.31% | $6.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 2.11M | 5.83% | $16.58M |
| Knott david m jr | 970.00K | 3.53% | $7.61M |
| Parkman healthcare partners | 1.79M | 1.52% | $14.58M |
| Essex investment management | 750.03K | 0.93% | $6.11M |
| Centerbook partners lp | 1.39M | 0.53% | $10.92M |
| Redmile group | 451.10K | 0.36% | $3.67M |
| Alphacentric advisors | 43.39K | 0.34% | $340.63K |
| Kennedy capital management | 1.21M | 0.22% | $9.86M |
| Entrypoint capital | 68.08K | 0.21% | $534.45K |
| Ausbil investment management | 37.00K | 0.17% | $290.45K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 11.19M | 0.00% | 1.36M |
| Charles schwab investment management | 1.45M | 0.00% | 879.08K |
| Norges bank | 800.70K | 0.00% | 800.70K |
| Blackrock funding, inc. /de | 12.64M | 0.00% | 711.62K |
| Centerbook partners lp | 1.39M | 0.53% | 693.39K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Aigh capital management | - | - | -2.57M |
| Caxton | - | - | -2.02M |
| Ubs group | 601.83K | 0.00% | -1.18M |
| Renaissance | 619.66K | 0.01% | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 800.70K | 0.00% | 800.70K | $6.29M |
| Divisadero street capital management, lp | 406.33K | 0.14% | 406.33K | $3.31M |
| Canada pension plan investment board | 375.70K | 0.00% | 375.70K | $3.06M |
| Granahan investment management | 350.17K | 0.12% | 350.17K | $2.85M |
| Trexquant investment lp | 229.42K | 0.02% | 229.42K | $1.87M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| Wealthtrak capital management | -40.00 |
| Bryn mawr trust | -40.00 |
| American capital advisory | -50.00 |
| Stephens consulting | -65.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 156 | -34.18% | 64,478,323 | -33.69% | 36 | 0.93% | 74 | -46.76% | 51 | -15.00% |
| Sep 30, 2025 | 137 | -33.50% | 56,532,097 | -37.58% | 36 | 1.07% | 80 | -25.23% | 33 | -43.10% |
| Jun 30, 2025 | 205 | - | 90,532,231 | 4.30% | 58 | 1.79% | 106 | -17.83% | 58 | 45.00% |
| Mar 31, 2025 | 204 | 24.39% | 86,739,126 | 32.43% | 56 | 2.94% | 129 | 46.59% | 39 | 14.71% |
| Dec 31, 2024 | 68 | -53.42% | 28,055,641 | -56.11% | 18 | 1.02% | 34 | -53.42% | 9 | -73.53% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.95M | 2.98% | - |
| Vanguard US Total Market Shares ETF | 4.25M | 2.76% | - |
| iShares Russell 2000 ETF | 3.71M | 2.24% | 1.07M |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.79M | 1.08% | -5.21K |
| CREF Stock R1 | 1.48M | 0.96% | - |
| Fidelity Small Cap Index | 1.54M | 0.93% | 5.05K |
| iShares Russell 2000 Growth ETF | 1.28M | 0.77% | 152.40K |
| Nuveen Quant Small Cap Equity R6 | 1.22M | 0.74% | -10.59K |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 1.04M | 0.63% | -8.93K |
| CREF Stock R3 | 872.07K | 0.54% | 294.50K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Hecht Beth | See Remarks | Sell | $103.38K |
| Mar 02, 2026 | Hecht Beth | See Remarks | Sell | $706.00 |
| Feb 02, 2026 | Hecht Beth | See Remarks | Sell | $124.15K |
| Jan 08, 2026 | McCulloch Kevin | See Remarks | Sell | $120.00K |
| Jan 05, 2026 | Shannon John Patrick Jr | See Remarks | Sell | $176.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 1 |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools